Schonfeld Strategic Advisors LLC

Position in ABCL — AbCellera Biologics Inc.

CIK 1665241 NEW YORK, NY

Position in ABCL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$493,119

+$426,156 QoQ

Shares Held

141,295

+621.6% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$493,119	141,295	+621.6%	Shares	Sole	2026-05-15
2025-12-31	$66,963	19,580	-94.5%	Shares	Sole	2026-02-17
2023-09-30	$1,648,640	358,400	+143.1%	Shares	Sole	2023-11-14
2023-06-30	$952,204	147,400	+80.0%	Shares	Sole	2023-08-14
2023-03-31	$617,526	81,900	-47.1%	Shares	Sole	2023-05-15
2022-12-31	$1,568,124	154,800	-30.5%	Shares	Sole	2023-02-14
2022-09-30	$2,202,503	222,700	+61.0%	Shares	Sole	2022-11-14
2022-06-30	$1,472,895	138,300	+11.6%	Shares	Sole	2022-08-15
2022-03-31	$1,208,025	123,900	+115.3%	Shares	Sole	2022-05-16
2021-09-30	$1,153,101	57,540	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.